Literature DB >> 15378064

Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans.

Daniel L Chase1, Judy S Pepper, Michael R Koelle.   

Abstract

D1-like and D2-like dopamine receptors have synergistic and antagonistic effects on behavior. To understand the mechanisms underlying these effects, we studied dopamine signaling genetically in Caenorhabditis elegans. Knocking out a D2-like receptor, DOP-3, caused locomotion defects similar to those observed in animals lacking dopamine. Knocking out a D1-like receptor, DOP-1, reversed the defects of the DOP-3 knockout. DOP-3 and DOP-1 have their antagonistic effects on locomotion by acting in the same motor neurons, which coexpress the receptors and which are not postsynaptic to dopaminergic neurons. In a screen for mutants unable to respond to dopamine, we identified four genes that encode components of the antagonistic Galpha(o) and Galpha(q) signaling pathways, including Galpha(o) itself and two subunits of the regulator of G protein signaling (RGS) complex that inhibits Galpha(q). Our results indicate that extrasynaptic dopamine regulates C. elegans locomotion through D1- and D2-like receptors that activate the antagonistic Galpha(q) and Galpha(o) signaling pathways, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378064     DOI: 10.1038/nn1316

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  137 in total

1.  Coexpressed D1- and D2-like dopamine receptors antagonistically modulate acetylcholine release in Caenorhabditis elegans.

Authors:  Andrew T Allen; Kathryn N Maher; Khursheed A Wani; Katherine E Betts; Daniel L Chase
Journal:  Genetics       Date:  2011-04-21       Impact factor: 4.562

2.  Chemosensory cue conditioning with stimulants in a Caenorhabditis elegans animal model of addiction.

Authors:  Heather N Musselman; Bethany Neal-Beliveau; Richard Nass; Eric A Engleman
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

3.  Goalpha regulates olfactory adaptation by antagonizing Gqalpha-DAG signaling in Caenorhabditis elegans.

Authors:  Masahiro Matsuki; Hirofumi Kunitomo; Yuichi Iino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

Review 4.  Dopamine signaling architecture in Caenorhabditis elegans.

Authors:  Paul W McDonald; Tammy Jessen; Julie R Field; Randy D Blakely
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

5.  Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.

Authors:  Marketa Marvanova; Charles D Nichols
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

Review 6.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

7.  Haloperidol Interactions with the dop-3 Receptor in Caenorhabditis elegans.

Authors:  Bárbara Nunes Krum; Airton C Martins; Libânia Queirós; Beatriz Ferrer; Ginger L Milne; Félix Alexandre Antunes Soares; Roselei Fachinetto; Michael Aschner
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

8.  BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Atbin Doroodchi; Hong Xing; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Tracy L Johnson; Stefan Clemens; Fumiaki Yokoi; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Brain Struct Funct       Date:  2020-05-28       Impact factor: 3.270

9.  Dopamine counteracts octopamine signalling in a neural circuit mediating food response in C. elegans.

Authors:  Satoshi Suo; Joseph G Culotti; Hubert H M Van Tol
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

10.  Regulation of serotonin biosynthesis by the G proteins Galphao and Galphaq controls serotonin signaling in Caenorhabditis elegans.

Authors:  Jessica E Tanis; James J Moresco; Robert A Lindquist; Michael R Koelle
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.